Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00034957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
October 31, 2002
Enrollment
Not reported
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, lung neoplasms